darzalex 100mg/5ml inj 100 mg/5ml
مستودع أدوية أداتكو - adatco drug store - daratumumab 100 mg/5ml - 100 mg/5ml
darzalex 400mg/20 ml inj 400 mg/20ml
مستودع أدوية أداتكو - adatco drug store - daratumumab 400 mg/20ml - 400 mg/20ml
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
sodium bicarbonate solution for infusion
liqvor cjsc - sodium bicarbonate - solution for infusion - 84mg/ml
tramadol alkaloid solution for injection
alkaloid ad skopje - tramadol (tramadol hydrochloride) - solution for injection - 100mg/2ml
implicor 50mg/7.5mg tablets film-coated
les laboratoires servier industrie - metoprolol (metoprolol tartrate), ivabradine (ivabradine hydrochloride) - tablets film-coated - 50mg+ 7,5mg
tyrez tablets film-coated
alkaloid ad skopje - bisoprolol (bisoprolol fumarate) - tablets film-coated - 10mg
tyrez tablets film-coated
alkaloid ad skopje - bisoprolol (bisoprolol fumarate) - tablets film-coated - 5mg
tyrez tablets film-coated
alkaloid ad skopje - bisoprolol (bisoprolol fumarate) - tablets film-coated - 2,5mg
vyvanse 50 mg
medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established